The effect of inhaled salbutamol on lung function and endurance performance in healthy well-trained athletes
Deutscher übersetzter Titel: | Auswirkung von Salbutamol-Inhalation auf Lungenfunktion und Ausdauerleistung von gesunden durchtrainierten Sportlern |
---|---|
Autor: | Carlsen, K.H.; Ingjer, F.; Kirkegaard, H.; Thyness, B. |
Erschienen in: | Scandinavian journal of medicine & science in sports |
Veröffentlicht: | 7 (1997), 3, S. 160-165, Lit. |
Format: | Literatur (SPOLIT) |
Publikationstyp: | Zeitschriftenartikel |
Medienart: | Gedruckte Ressource Elektronische Ressource (online) |
Sprache: | Englisch |
ISSN: | 0905-7188, 1600-0838 |
DOI: | 10.1111/j.1600-0838.1997.tb00133.x |
Schlagworte: | |
Online Zugang: | |
Erfassungsnummer: | PU199710207721 |
Quelle: | BISp |
Abstract des Autors
The present randomized, double-blind placebo-controlled study aimed at investigating the possible improvement in endurance performance caused by inhaled salmeterol (long-acting beta2-agonist) and salbutamol (short-acting) compared to placebo in 18 healthy well-trained athletes, aged 17-30 years old. Lung function (flow-volume loops) was measured before and after each inhaled study drug and after run to exhaustion. After inhalation of study drug and 10 min warm-up, anaerobic threshold was measured; thereafter maximum oxygen uptake, peak ventilation and running time until exhaustion during a brief graded exercise were measured. No significant differences were found for ventilation, oxygen uptake or heart rate at anaerobic threshold or at maximum performance between placebo and the beta2-agonists. Lung function increased significantly after exercise, but without differences between the beta2-agonists and placebo. Running time till exhaustion was significantly reduced after both the long- und the short-acting beta2-agonist compared to the placebo. Verf.-Referat